Zeiss is now offering the new Selective Laser Trabeculoplasty (SLT) add-on to its VISULAS green laser, which will be showcased at two upcoming RANZCO events.
Building on 25 years of innovation in glaucoma and more than half a century of innovation in therapeutic laser technology, the new SLT add-on is part of an integrated glaucoma workflow to help advance safe and effective glaucoma treatment.
The new Zeiss SLT add-on will be showcased at RANZCO’s NSW branch combined Annual Scientific Meeting in August in Sydney, and at the RANZCO 53rd Annual Scientific Congress in October in Brisbane.
According to Zeiss, the new SLT laser feature offers unique protocols that may improve care for glaucoma patients.
“Based on the selective photothermolysis effect, Zeiss SLT is a safe and effective therapy for lowering the intraocular pressure within the treatment of primary open-angle glaucoma,” the company said.
It said the intuitive operation of the Zeiss VISULAS green laser and the premium image quality of Zeiss laser slit lamps enables a fast and comfortable procedure for both the doctor and the patient.
“The convenient integration of Zeiss VISULAS green into the Zeiss ecosystem provides high levels of flexibility and efficiency,” the company said.
“With optional image and video recording capabilities to improve digital documentation and access to historical diagnostic data on the panel PC, clinicians can now check the patient condition and intraocular pressure trends within FORUM Glaucoma Workplace on the VISULAS workstation prior to treatment.”
Learn more about Zeiss glaucoma innovations here.